[Drug-induced dyschromatopsias].
D000962:Antimalarials / Q000009:adverse effects; D001927:Brain Diseases / Q000139:chemically induced; D003118:Color Perception; D003119:Color Perception Tests; D003276:Contraceptives, Oral / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000009:adverse effects; D004221:Disulfiram / Q000009:adverse effects; D004977:Ethambutol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008722:Methods; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D012164:Retinal Diseases / Q000139:chemically induced*; D012500:Santonin / Q000009:adverse effects; D014786:Vision Disorders / Q000139:chemically induced / Q000175:diagnosis; D014795:Visual Pathways
D000962:Antimalarials; D003276:Contraceptives, Oral; D004071:Digitalis Glycosides; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D012500:Santonin; D004977:Ethambutol; D004221:Disulfiram
Les dyschromatopsies pharmacogènes.